Detalhe da pesquisa
1.
Pharmacovigilance of unlicensed cannabidiol in European countries.
Phytother Res
; 38(1): 74-81, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37800192
2.
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance.
Pharmaceuticals (Basel)
; 17(3)2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543150
3.
Effects of Physical Exercise and Motor Activity on Depression and Anxiety in Post-Mastectomy Pain Syndrome.
Life (Basel)
; 14(1)2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255692
4.
Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database.
Pharmaceutics
; 15(7)2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37514118
5.
Suspected oncologic adverse reactions associated with interleukin-23 inhibitors in EudraVigilance: Comparative study and gender distribution.
Pharmacol Res Perspect
; 11(5): e01130, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37615258
6.
Response to "Evaluating Adverse Events in Databases".
Pharmacol Res Perspect
; 11(5): e01127, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589310